BioCryst Pharmaceuticals, Inc.
BCRX
$9.81
$0.657.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.37% | -35.50% | -4.41% | -12.32% | -17.52% |
| Total Receivables | 35.09% | 26.04% | 32.60% | 54.15% | 38.84% |
| Inventory | -33.25% | -30.81% | 13.35% | -76.92% | -71.81% |
| Prepaid Expenses | 24.94% | 1.36% | -23.65% | -22.06% | -29.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.29% | 3,559.53% | 1,552.48% | -83.82% | -88.36% |
| Total Current Assets | -4.18% | -16.73% | 9.63% | -8.30% | -14.92% |
|
|
|||||
| Total Current Assets | -4.18% | -16.73% | 9.63% | -8.30% | -14.92% |
| Net Property, Plant & Equipment | -4.04% | -2.01% | 0.77% | -5.49% | -5.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.65% | 26.97% | 15.44% | 37,807.59% | 35,330.00% |
| Total Assets | 4.84% | -9.13% | -3.22% | 2.60% | -5.13% |
|
|
|||||
| Total Accounts Payable | 35.92% | -58.71% | 10.31% | -15.63% | -44.27% |
| Total Accrued Expenses | 11.58% | 13.99% | 19.55% | 16.89% | 10.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.08% | 9.98% | 19.15% | 29.24% | 35.23% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 22.25% | 23.88% | 37.26% | 16.62% | 6.93% |
|
|
|||||
| Total Current Liabilities | 22.25% | 23.88% | 37.26% | 16.62% | 6.93% |
| Long-Term Debt | -46.32% | -20.43% | -14.58% | -3.81% | -1.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.36% | 0.25% | 0.51% | -9.09% | -10.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -34.46% | -13.08% | -7.30% | -1.28% | -0.63% |
|
|
|||||
| Common Stock & APIC | 7.25% | 7.12% | 7.07% | 6.24% | 5.63% |
| Retained Earnings | 14.91% | -0.50% | -2.07% | -3.11% | -5.29% |
| Treasury Stock & Other | -95.87% | -50.28% | 195.51% | 46.82% | -31.11% |
| Total Common Equity | 74.96% | 17.22% | 11.36% | 5.09% | -4.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 74.96% | 17.22% | 11.36% | 5.09% | -4.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 74.96% | 17.22% | 11.36% | 5.09% | -4.48% |
|
|
|||||